bpc 157 cuprizone demyelination model & Remyelination in the Dynamic Transcriptomic and Cellular Remodeling

Only at the highest research doses of 2.4mg weekly does the vial deplete quickly, lasting roughly 2 doses

193 Recent analyses have shown that ECM remodeling is not a static process but a dynamic niche that evolves with tumor progression, simultaneously supporting cancer cell proliferation, invasion, and immune evasion while also hindering drug accessibility

There are more than 40 options on one peptide site called Olympic Peptide (I wonder what they are going after with that name)

These effects are mediated by modulation of neurotransmitters (serotonergic, dopaminergic) and preservation of the blood-brain barrier